XML 34 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisition of Hema Diagnostics Systems, LLC (Tables)
3 Months Ended
Oct. 31, 2018
Business Combinations [Abstract]  
Net purchase price of HDS
    Stock Price at Closing   Shares  

Fair

Value

Purchase price:                        
Common Stock at closing   $ .23       1,117,011     $ 253,721  
Common Stock after closing   $ .23       420       95  
Common Stock post reverse stock split   $ .23       4,830,000       1,097,100  
Total purchase price             5,947,431     $ 1,350,916  
Fair Value Assumptions Used in Accounting for Warrants
    October 31, 2018   July 31, 2018
Exercise price     2.50       2.50  
Time to expiration     3.26 years       3.47 years  
Risk-free interest rate     3.15 %     2.77 %
Estimated volatility     135.07 %     143.97 %
Dividend     —         —    
Stock price at valuation date   $ 0.47     $ 0.1  
Fair Value Assumptions Used in Accounting for Call Options
    October 31, 2018   July 31, 2018
Risk-free interest rate     2.49 %     2.44 %
Estimated volatility     128.52 %     129.95 %
Remaining Term     1.22 years       1.47 years  
Stock price at valuation date   $ 0.4975     $ 0.0976